Plenty of us experience tinnitus - an awareness of a persistent and unpleasant ringing in the ears that can make life ...
Neuromod has closed a €10m round of equity financing as it looks to expand the availability of its tinnitus treatment device ...
An innovative treatment offers hope to the millions of people who hear sounds that others don’t. Here’s how it works. Warning: This graphic requires JavaScript ...
Neuromod Devices has secured €10m ($10.8m) in equity financing to broaden the reach of Lenire, its treatment device.
According to Neuromod, Lenire is the “first” non-invasive bimodal neuromodulation tinnitus treatment shown to soothe and relieve tinnitus. Neuromodulation is technology that directly acts upon ...
It affects about one in eight people. The group’s treatment device, Lenire, has been shown to soothe and relieve tinnitus in large-scale clinical trials. It works by delivering mild electrical ...
35 USVA facilities have been trained to provide treatment with Lenire with more scheduled for training in 2025. Positive results for tinnitus patients treated with Lenire in real-world settings at ...
Neuromod Devices Ltd. raised €10 million (US$10.9 million) in financing to expand the reach of Lenire, which treats tinnitus.
35 USVA facilities have been trained to provide treatment with Lenire with more scheduled for training in 2025. Real-World Evidence – Substantial Momentum Positive results for tinnitus patients ...